Search

everythinglearnresearchcommunity

for

Search:↓

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Both treatments for alopecia areata showed similar modest effectiveness.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Consider benefits and risks of new alopecia treatments for safety.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

New treatments like JAK inhibitors show promise for reversing alopecia areata.